Johnson & Johnson stock slips on talc verdict — what JNJ investors watch after the holiday
A Philadelphia jury ordered Johnson & Johnson to pay $250,000 in a talc baby-powder cancer case Friday. Shares closed down 0.45% at $243.45, trailing the health-care sector. The company plans to appeal. U.S. markets will be closed Monday for Presidents Day.